Clinical Trials Browser

Phase 2 × Enrolling by invitation × Carcinoma, Hepatocellular × Clear all

NCT05441475 2026-02-25

A Phase 2, Open-Label Study of ABSK-011 Combined Atezolizumab or SOC in HCC Patients

Phase 2 Enrolling by invitation

Gastrointestinal

Carcinoma, Hepatocellular

NCT05171335 2022-09-21

Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma Patients

Phase 2 Enrolling by invitation

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms